Skip to main content
OpenTrials

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

853 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Macular Degeneration trial results

Active, Not Recruiting

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

NCT04645212

Conditions
Blindness, Choroid Diseases, Choroidal Neovascularization, +18 more
Locations
  • Adverum Clinical Site Bakersfield, California, United States
  • Adverum Clinical Site Beverly Hills, California, United States
  • Adverum Clinical Site Lakewood, Colorado, United States
  • Adverum Clinical Site Deerfield Beach, Florida, United States
View Trial Details
Active, Not Recruiting

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

NCT05984927

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +11 more
Locations
  • Cincinnati Eye Institute Cincinnati, Ohio, United States
  • Retina Consultants of Texas Bellaire, Texas, United States
  • Vancouver Coastal Health Research Institute Vancouver, British Columbia, Canada
  • Sunnybrook Ophthalmology and Vision Services Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration

NCT06825858

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Kanghong Investigative Site Phoenix, Arizona, United States
  • Kanghong Investigative Site Lemont, Illinois, United States
  • Kanghong Investigative Site Memphis, Tennessee, United States
View Trial Details
Active, Not Recruiting

Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration

NCT05657301

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Kanghong Investigative Site Phoenix, Arizona, United States
  • Kanghong Investigative Site Lemont, Illinois, United States
  • Kanghong Investigative Site Boston, Massachusetts, United States
  • Kanghong Investigative Site Reno, Nevada, United States
View Trial Details
Active, Not Recruiting

A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

NCT05839041

Conditions
Eye Diseases, Geographic Atrophy, Geographic Atrophy of the Macula, +3 more
Locations
  • Associated Retina Consultants Gilbert, Arizona, United States
  • Arizona Retina and Vitreous Consultants Phoenix, Arizona, United States
  • Associated Retina Consultants Scottsdale, Arizona, United States
  • Retina Vitreous Associates Medical Group Beverly Hills, California, United States
View all 56 locations
View Trial Details

Related conditions